Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, May 05, 2015 12:46:28 PM
bullish
bullish engulfing
## source: finance.yahoo.com
Wed, 29 Apr 2015 22:15:16 GMT ~ Nasdaq stocks posting largest percentage decreases
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************
Tue, 28 Apr 2015 12:38:12 GMT ~ Atara Biotherapeutics (ATRA) Falls: Stock Goes Down 19.4% - Tale of the Tape
read full: http://finance.yahoo.com/news/atara-biotherapeutics-atra-falls-stock-123812970.html
*********************************************************
Mon, 20 Apr 2015 10:46:49 GMT ~ EBV-CTL Clinical Trial Data Presented by Atara Biotherapeutics' Collaborating Investigators at a Plenary Session at the American Association for Cancer Research Annual Meeting 2015
[at noodls] - SOUTH SAN FRANCISCO, Calif., April 20, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) today announced that its collaborating investigators at Memorial Sloan Kettering Cancer Center ...
read full: http://www.noodls.com/view/F5E86C4ED97E6021996505EB6A500C5F8341F79F
*********************************************************
Mon, 20 Apr 2015 10:30:00 GMT ~ EBV-CTL Clinical Trial Data Presented by Atara Biotherapeutics' Collaborating Investigators at a Plenary Session at the American Association for Cancer Research Annual Meeting 2015
[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif. -- Atara Biotherapeutics, Inc. today announced that its collaborating investigators at Memorial Sloan Kettering Cancer Center (MSK) presented data on its investigational cytotoxic ...
read full: http://finance.yahoo.com/news/ebv-ctl-clinical-trial-data-103000068.html
*********************************************************
Sun, 19 Apr 2015 12:55:12 GMT ~ Atara Biotherapeutics' Collaborating Investigators' Abstract on T-Cell Therapy for EBV Lymphoma to be Presented at a Clinical Trials Plenary Session at the American Association for Cancer Research Annual Meeting 2015 is Now Available
[at noodls] - SOUTH SAN FRANCISCO, Calif., April 19, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), today announced that the abstract on cytotoxic T lymphocytes activated against Epstein-Barr Virus ...
read full: http://www.noodls.com/view/CFC4866E6F03B003009024E6E4A9953CC6962A7A
*********************************************************
$ATRA charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ATRA company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ATRA/company-info
Ticker: $ATRA
OTC Market Place: Not Available
CIK code: not found
Company name: Atara Biotherapeutics, Inc.
Incorporated In:
$ATRA share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$ATRA extra dd links
Company name: Atara Biotherapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ATRA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ATRA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ATRA+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ATRA/news - http://finance.yahoo.com/q/h?s=ATRA+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ATRA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ATRA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ATRA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ATRA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Atara+Biotherapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Atara+Biotherapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Atara+Biotherapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ATRA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ATRA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ATRA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ATRA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ATRA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ATRA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ATRA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ATRA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ATRA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ATRA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ATRA+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ATRA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ATRA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ATRA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ATRA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ATRA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ATRA/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ATRA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ATRA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ATRA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ATRA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ATRA
$ATRA DD Notes ~ http://www.ddnotesmaker.com/ATRA
Recent ATRA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:11:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:05:59 PM
- Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress • Business Wire • 05/09/2024 08:01:00 PM
- Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/03/2024 08:01:00 PM
- Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/05/2024 08:01:00 PM
- Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress • Business Wire • 03/28/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:17:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:16:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:21:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:19:27 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:18:30 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:17:14 AM
- Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy • Business Wire • 02/29/2024 02:05:00 PM
- Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 44th Annual Health Care Conference • Business Wire • 02/28/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:30:14 PM
- Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis • Business Wire • 02/14/2024 02:00:00 PM
- Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology • PR Newswire (US) • 02/01/2024 07:25:00 AM
- Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology • Business Wire • 01/31/2024 11:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:41:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:40:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:40:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:40:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:40:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/09/2024 09:28:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:01:57 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM